1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsHepConnect is sponsored by Gilead Sciences. A five-year initiative addressing the intersecting opioid and hepatitis C virus (HCV) epidemics in Indiana, Kentucky, North Carolina, Tennessee, and West Virginia.
Get alerted about grants like this
Save a search for “Gilead Sciences” or related topics and get emailed when new opportunities appear.
Search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Gilead Sciences: HepConnect Addressing the Increase in Hepatitis C Fueled by the Opioid Crisis HepConnect supports programs and services designed to reach people in need.
In response to the intersecting opioid and hepatitis C virus (HCV) epidemics in the U.S., in 2019 we launched HepConnect, a five-year, multi-million-dollar initiative to help address the increase in HCV and support community partnerships in Indiana, Kentucky, North Carolina, Tennessee and West Virginia.
HepConnect has three areas of focus: Expand Screening and Linkage to Care Support Harm Reduction and Community Education Activate Healthcare Infrastructure Expand Screening and Linkage to Care HepConnect supports local community partnerships to expand testing for the virus and support access to healthcare. HCV does not always cause symptoms immediately. Testing is the first step to ensure people receive treatment.
Access to healthcare can be difficult in rural areas, including much of greater Appalachia. Many residents of the region lack insurance coverage, limiting their ability to get the care they need. Support Harm Reduction and Community Education Opening doors to harm reduction services can help reduce HCV transmission.
HepConnect helps community partnerships and prevention programs: Implement and expand evidence-based, practical strategies that can have a real impact on affected populations and their surrounding communities, including Medication Assisted Treatment (MAT) programs and Syringe Exchange Programs (SEPs). Remove barriers to services that are a critical part of the continuum of care and proven to reduce HCV rates.
Make harm reduction services available to all who need them. Activate Healthcare Infrastructure Building resources, know-how and capacity in communities where the need is greatest can make a difference. HepConnect works to: Educate and expand the number of healthcare providers able to care for people with HCV across the region.
Support the implementation of telemedicine and other innovative programs that reach people where they are. Develop local solutions, as they can be the most effective in combating rising rates of HCV. HepConnect grantees are making an impact.
According to the current listing, eligibility includes: Local community partnerships and prevention programs in Indiana, Kentucky, North Carolina, Tennessee, and West Virginia working to expand HCV testing, support harm reduction services, and activate healthcare infrastruct…. Confirm the full requirements in the official notice before applying.
HepConnect is funded by Gilead Sciences. Verify program details on the funder's official page before applying.
This opportunity targets applicants in North Carolina, West Virginia, Tennessee, Kentucky, and Indiana. Check the official notice for exact location requirements.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Schmidt Sciences' 2026 Science of Trustworthy AI RFP closes May 17 with two funding tiers — up to $1M (Tier 1) and $1–5M+ (Tier 2) over 1–3 years, with a 10% indirect cost cap. The three research aims target misalignment under distribution shift, predictive-validity evaluations, and oversight of superhuman systems. Here is why the structure favors team-based proposals.
Read articleAwards slashed by half, life sciences applicants rejected at 95%, and the White House steering which fields get funded. How the GRFP went from funding the person to funding the priority.
Read articleThe DSO DPA26BZ03 drop pairs a wearable closed-loop sleep system and a host-pathogen interactome predictor with a brutal Rydberg-sensor manufacturing topic and air-independent high-density batteries. All four open June 24 and close July 22, 2026. Here is what each topic is really asking for, and which small businesses are positioned to win.
Read article